Several studies have reported that DNA methylation of the SERPINB5 promoter negatively correlated with gene expression in human cancer and that 5-aza-2′-deoxycytidine treatment is sufficient to restore SERPINB5 expression71–75. This evidence concerns the gene SERPINB5 and cancer.